Sort
40,608 grants matching “prostate cancer”
TARGET-GUIDED DEVELOPMENT OF SPECIFIC AKT INHIBITORS
$435,148Peter K Vogt · Scripps Research Institute, The · R01 · FY2007 · CA
The Role of YY1 in Castration-Resistant Prostate Cancer
$435,136Ling Cai · Duke University · R01 · FY2023 · CA
Molecular Phenotyping and Image-Guidance for Surgical Treatment of High-Risk Prostate Cancer Using Ultrasmall Silica Nanoparticles
$435,128Michelle S Bradbury · Sloan-Kettering Inst Can Research · R01 · FY2021 · CA
A genomewide study of lung cancer in never smokers
$435,109Olga Gorlova · Dartmouth College · R01 · FY2014 · CA
SOUTHWEST ONCOLOGY GROUP/UNIVERSITY OF CALIFORNIA, DAVIS
$435,092University Of California Davis · U10 · FY2003 · CA
METABOLIC IMAGING OF THE PROSTATE USING 3-D MRSI
$435,081Daniel B Vigneron · University Of California, San Francisco · R01 · FY2010 · CA
AKT-independent Pathways of Phosphoinositide 3-kinase dependent transformation
$435,028Charles L Sawyers · Beth Israel Deaconess Medical Center · P01 · FY2010 · CA
AIF-mediated Control of Mitochondrial Biogenesis, Metabolism, and Cellular Redox Balance
$435,000John Curlee Wilkinson · North Dakota State University · R15 · FY2016 · CA
Development of Next Generation Galeterone Analogs for Prostate Cancer Therapy
$434,965Vincent Collins Ofuka Njar · University Of Maryland Baltimore · R01 · FY2019 · CA
Mechanisms of prostate cancer prevention by Korean Angelica
$434,941Junxuan Lu · Texas Tech University Health Scis Center · R01 · FY2012 · AT
Determine the Microphthalmia Transcription Factor (MITF)-regulated cell rewiring mechanisms in lethal prostate cancer
$434,911Josep Maria Domingo-Domenech · Mayo Clinic Rochester · R01 · FY2024 · CA
Defining the Role of Tumor-Neural Crosstalk in head and Neck Cancer Progression and Treatment Resistance
$434,780Moran Amit · University Of Tx Md Anderson Can Ctr · R37 · FY2024 · CA
Ultrasound Imaging and Therapy for Prostate Cancer
$434,744Focus Surgery, Inc. · R44 · FY2004 · DK
Transport of Effector T cells and Nano-DC vaccine in Breast Cancer
$434,685Elizabeth Mittendorf · Methodist Hospital Research Institute · U54 · FY2017 · CA
CNS sirtuins in radiation-induced vascular permeability and neurodegeneration
$434,670Deedee Smart · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Therapeutic targeting of CD206+ TAMs to enhance adaptive and innate anti-tumor immune responses in metastatic castration-resistant prostate cancer
$434,649Jelani Chinelo Zarif · Johns Hopkins University · R01 · FY2024 · CA
Influence of bone microenvironment on drug resistance in prostate cancer bone metastasis
$434,625Xiaohong Li · Van Andel Research Institute · R01 · FY2019 · CA
Imaging Habitats in Sarcoma
$434,604Robert J Gillies · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2019 · CA
Leadership, Administrative, and Food Composition Core
$434,562Walter C. Willett · Harvard School Of Public Health · P01 · FY2008 · CA
Targeting LSD1 to prevent therapy-induced transdifferentiation in BRAF mutant colorectal cancer
$434,552Heather M O'Hagan · Indiana University Indianapolis · R01 · FY2025 · CA
Developmental Funds
$434,458Michelle M Le Beau · University Of Chicago · P30 · FY2020 · CA
Developmental Funds
$434,458Kunle Odunsi · University Of Chicago · P30 · FY2021 · CA
Developmental Funds
$434,458Michelle M Le Beau · University Of Chicago · P30 · FY2019 · CA
Clinical Protocol and Data Management
$434,303Susanne M Arnold · University Of Kentucky · P30 · FY2024 · CA
Energetic Factors, Lethal Prostate Cancer, and Survivorship
$434,263Jing Ma · Harvard School Of Public Health · U54 · FY2015 · CA